| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $44.0M | -6.8% |
| Cost of Revenue | $26.3M | -4.1% |
| Gross Profit | $17.7M | -10.6% |
| R&D Expense | $2.5M | -0.1% |
| SG&A Expense | $3.9M | +12.8% |
| Operating Income | -$3.0M | -310.0% |
| Pre-tax Income | -$2.7M | -296.0% |
| Income Tax | -$499K | -186.6% |
| Net Income | -$2.2M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.4M | +9.0% |
| Accounts Receivable | $6.4M | -8.0% |
| Inventory | $18.0M | -11.8% |
| Current Assets | $41.2M | -2.7% |
| Total Assets | $46.5M | -2.3% |
| Current Liabilities | $7.9M | +17.3% |
| Long-term Debt | $31K | -78.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.8M | -58.0% |
| Investing Cash Flow | -$1.2M | +38.4% |
| Financing Cash Flow | -$515K | — |
| -374.5% |
| EPS (Basic) | -$0.35 | -369.2% |
| EPS (Diluted) | -$0.34 | -361.5% |
| Stockholders' Equity |
| $38.3M |
| -5.0% |